Prostate Biopsy

A prostate biopsy is a diagnostic procedure that removes small tissue samples from the prostate gland, usually guided by ultrasound or MRI, to check for the presence of prostate cancer following an abnormal PSA test or examination. It remains the only way to definitively confirm or rule out prostate cancer, since elevated PSA levels or an abnormal examination can also result from benign conditions. Modern MRI-guided or MRI-fused biopsy techniques allow more targeted sampling of suspicious areas, improving detection accuracy compared with older random sampling methods. Antibiotics are typically given before and after the procedure to reduce the risk of infection from the biopsy needle passing through bacteria-containing tissue.

Prostate Biopsy is recommended for patients diagnosed with specific conditions where other approaches have been insufficient. Your Urology specialist will assess your suitability based on your diagnosis, health history, and treatment goals.

The typical duration is 15-30 minutes. This may vary based on the complexity of your case and individual response to treatment.

Recovery typically takes Mild soreness lasts a day or two, with antibiotics often given before and after to reduce infection risk. Blood-tinged urine or semen may persist for a few weeks, and results are typically available within seven to ten days.. Your care team will provide specific instructions based on your response and overall health.

Side effects vary by individual and are detailed in the section above. Your specialist will discuss all risks and benefits with you before treatment begins. Serious adverse effects are uncommon but are part of the informed consent process.

Prostate Biopsy has a documented success rate of 90-95% diagnostic accuracy at accredited facilities. Outcomes depend on disease stage, patient health, and adherence to the treatment plan and aftercare instructions.